Pet Healthcare Market Report 2026

The pet healthcare market size has grown strongly in recent years. It will grow from $269.01 billion in 2025 to $293.14 billion in 2026 at a compound annual growth rate (CAGR) of 9%. The growth in the historic period can be attributed to rising pet ownership, increasing disposable income, awareness about zoonotic diseases, expansion of veterinary infrastructure, growth of companion animal segment.

The pet healthcare market size is expected to see strong growth in the next few years. It will grow to $421.68 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to integration of telehealth and digital veterinary platforms, development of advanced pet therapeutics, growth in genetic and microbiome testing, rising demand for personalized pet nutrition, increased adoption of preventive care programs. Major trends in the forecast period include growing awareness of preventive pet healthcare, increase in routine health check-ups for pets, expansion of nutraceuticals and functional foods for pets, adoption of telemedicine and remote consultations, rising focus on multi-species pet health management.

The increasing pet ownership is expected to drive the growth of the pet healthcare market in the coming years. Pet ownership refers to being the primary individual or household responsible for the care, well-being, and management of a domesticated animal. It entails a long-term, legal, and ethical responsibility. The rise in pet ownership is attributed to growing awareness of the emotional and health benefits of having pets, as people seek companionship, stress relief, and enhanced well-being through pet care. Pet healthcare supports this growth by ensuring pets’ well-being and longevity through preventive care and by offering health education that enables new pet owners to make informed decisions regarding their animals' care. For example, in March 2025, according to the American Pet Products Association, a US-based non-profit organization, ninety-four (94) million U.S. households owned at least one pet, compared to eighty-two (82) million in 2023. Hence, the rising pet ownership is boosting the pet healthcare market.

Leading players in the pet healthcare market are introducing innovative digital platforms to maintain their market position. These innovative digital platforms include online tools and mobile applications that offer pet health monitoring, telemedicine, appointment scheduling, and personalized care recommendations. For instance, in October 2023, Cargill Incorporated, a US-based company, launched a pet health-focused digital platform called Zoonivet, designed to deliver convenient and accessible veterinary care through e-consultations. The platform aims to streamline pet healthcare by connecting pet owners with qualified veterinarians remotely via video for their pets' primary healthcare needs.

In December 2023, Zenex Animal Health, an animal health company based in India, successfully acquired Ayurveda for an undisclosed sum. This strategic acquisition is anticipated to enhance Zenex's product portfolio by incorporating herbal offerings, thereby improving the overall quality of its animal health products. Ayurvet, an India-based pet healthcare company, is known for its specialization in providing natural and safe Ayurvedic and herbal medicines tailored for pets. The integration of Ayurveda into Zenex Animal Health's operations represents a strategic move to further diversify and enhance the company's capabilities in the animal health sector.

Major companies operating in the pet healthcare market are Nestle SA, Merck & Co Inc., Mars Inc., Indian Immunologicals Limited, Boehringer Ingelheim International GmbH, Colgate-Palmolive Company, Chewy Inc., Zoetis Inc., Petco Animal Supplies Inc., VCA Animal Hospitals Inc., Elanco Animal Health Incorporated, IDEXX Laboratories Inc., Royal Canin, Ceva Santé Animale, Phibro Animal Health Corporation, Trupanion, Vetoquinol S.A., Norbrook Laboratories Ltd., Heska Corporation, Biogenesis Bago SA, Pumpkin Insurance Services Inc., PetFirst Healthcare LLC, Embark Veterinary Inc., Agrolabo SpA, Bayer Animal Health GmbH, Bioniche Animal Health Canada Inc., Novartis Animal Health US Inc.

North America was the largest region in the pet healthcare market in 2025. Asia-Pacific is expected to be the fastest-growing region in the global pet healthcare market report during the forecast period. The regions covered in the pet healthcare market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pet healthcare market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the pet healthcare market by increasing costs of imported vaccines, anti-infective drugs, imaging equipment, and specialized diagnostics. Segments such as therapeutics and diagnostics are most affected, particularly in North America, Europe, and Asia-Pacific where imports are significant. While tariffs may raise operational costs, they also encourage local production, innovation in domestic pet healthcare products, and the development of cost-effective diagnostic solutions.

The pet healthcare market research report is one of a series of new reports that provides pet healthcare market statistics, including pet healthcare industry global market size, regional shares, competitors with a pet healthcare market share, detailed pet healthcare market segments, market trends and opportunities, and any further data you may need to thrive in the pet healthcare industry. This pet healthcare market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Pet healthcare involves a comprehensive approach that combines preventive and therapeutic measures to maintain the well-being of pet animals and keep them free from diseases. This approach is instrumental in promoting a healthy pet lifestyle. It encompasses a multifaceted strategy, which includes regular assessments by a veterinarian to evaluate the pet's overall health and assess the potential for illnesses or other health issues.

The primary types of pet healthcare encompass therapeutics and diagnostics. Therapeutics include products such as vaccines, anti-parasitic medications, and feed additives, designed to treat already-infected pets. These therapeutic products cater to various types of animals, including canines, felines, equines, avian pets, and others. They are made available through diverse distribution channels, including retail outlets, e-commerce platforms, and hospital pharmacies, ensuring accessibility for pet owners seeking healthcare solutions for their animals.

The pet healthcare market consists of sales of pet healthcare diagnostic tools, medicines and preventive care products. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.